Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ototoxicity Monitoring and Remote Audiometry

NCT06662058 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT06662058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06662058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ototoxicity Monitoring and Remote Audiometry
Lead sponsor
Emory University
Phase
Not applicable
Overall status
Recruiting
Start date
August 25, 2025
Completion date
August 1, 2029
Enrollment
118 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, cutaneous squamous cell carcinoma of the head and neck, head and neck carcinoma of unknown primary, head and neck squamous cell carcinoma, hypopharyngeal squamous cell carcinoma, laryngeal squamous cell carcinoma, metastatic cutaneous squamous cell carcinoma of the head and neck, metastatic head and neck squamous cell carcinoma, metastatic hypopharyngeal squamous cell carcinoma, metastatic laryngeal squamous cell carcinoma, metastatic nasopharyngeal squamous cell carcinoma, metastatic oral cavity squamous cell carcinoma, metastatic oropharyngeal squamous cell carcinoma, metastatic paranasal sinus squamous cell carcinoma, nasopharyngeal squamous cell carcinoma, oral cavity squamous cell carcinoma, oropharyngeal squamous cell carcinoma, paranasal sinus squamous cell carcinoma, recurrent cutaneous squamous cell carcinoma of the head and neck, recurrent head and neck squamous cell carcinoma, recurrent hypopharyngeal squamous cell carcinoma, recurrent laryngeal squamous cell carcinoma, recurrent nasopharyngeal squamous cell carcinoma, recurrent oral cavity squamous cell carcinoma, recurrent oropharyngeal squamous cell carcinoma, recurrent paranasal sinus squamous cell carcinoma, stage iv cutaneous squamous cell carcinoma of the head and neck ajcc v8, stage iv hypopharyngeal carcinoma ajcc v8, stage iv laryngeal cancer ajcc v8, stage iv lip and oral cavity cancer ajcc v8, stage iv nasopharyngeal carcinoma ajcc v8, stage iv oropharyngeal (p16-negative) carcinoma ajcc v8, stage iv sinonasal cancer ajcc v8